Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
J Clin Lab Anal. 2020 Dec;34(12):e23516. doi: 10.1002/jcla.23516. Epub 2020 Aug 6.
Vitamin D deficiency plays an essential role in allergic rhinitis(AR), but the role of vitamin D deficiency in perennial allergic rhinitis (pAR) remains unclear. Therefore, our study explored 25(OH)D levels in patients with pAR and healthy individuals in a single center in China for three years.
A total of 655 patients with pAR and 682 healthy controls were enrolled in this study from 2015 to 2017. Patients' clinical history and symptoms were recorded. sIgE tests were performed using the allergen detection system (UniCAP), and the ADVIA centaur XP system (SIEMENS) was used to measure serum 25(OH)D levels.
Serum 25(OH)D levels were significantly different between the pAR group and control group over the three-year study period(all P < .05). Specifically, 25(OH)D levels were decreased in the pAR groups over three years. Serum25(OH)D deficiency, insufficiency, and sufficiency were noted in 66.9% 71.9%, 22.5% ~29.4%, and 2.5%5.6%, respectively, of patients in the pAR group and 53.2%60.7%, 31.4%36.6%, and 7.9% ~11.4%, respectively, of participants in the control group. We did not identify significant associations between serum 25(OH)D levels and clinical characteristics of patients with pAR over the three-year period (all P > .05) after adjusting for sex, age, duration of disease, total nasal symptom score (TNSS), sIgE levels, number of positive allergens, and family history.
pAR patients exhibited lower serum 25(OH)D levels compared with healthy people with a high prevalence of 25(OH)D deficiency or insufficiency. We did not identify a significant correlation between 25(OH)D and pAR associated factors.
维生素 D 缺乏在过敏性鼻炎(AR)中起着重要作用,但维生素 D 缺乏在常年性过敏性鼻炎(pAR)中的作用尚不清楚。因此,我们在 3 年内对中国单一中心的 pAR 患者和健康个体进行了 25(OH)D 水平研究。
本研究共纳入 2015 年至 2017 年间的 655 例 pAR 患者和 682 名健康对照者。记录患者的临床病史和症状。采用过敏原检测系统(UniCAP)进行 sIgE 检测,采用 ADVIA centaur XP 系统(SIEMENS)测量血清 25(OH)D 水平。
在 3 年的研究期间,pAR 组和对照组之间的血清 25(OH)D 水平存在显著差异(均 P<.05)。具体来说,pAR 组患者 3 年内 25(OH)D 水平下降。pAR 组患者中,血清 25(OH)D 缺乏、不足和充足的比例分别为 66.9%71.9%、22.5%29.4%和 2.5%5.6%,而对照组中,血清 25(OH)D 缺乏、不足和充足的比例分别为 53.2%60.7%、31.4%36.6%和 7.9%11.4%。调整性别、年龄、病程、总鼻症状评分(TNSS)、sIgE 水平、阳性过敏原数和家族史后,我们未发现 3 年内血清 25(OH)D 水平与 pAR 患者临床特征之间存在显著相关性(均 P>.05)。
与健康人群相比,pAR 患者血清 25(OH)D 水平较低,且 25(OH)D 缺乏或不足的发生率较高。我们未发现 25(OH)D 与 pAR 相关因素之间存在显著相关性。